Effects of estrogen treatment on human testicular unconjugated steroid and steroid sulfate production in vivo.
D000328:Adult; D000368:Aged; D000728:Androgens / Q000378:metabolism*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004054:Diethylstilbestrol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004958:Estradiol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D045166:Estradiol Congeners / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D011284:Pregnenolone / Q000378:metabolism; D011374:Progesterone / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D013256:Steroids / Q000378:metabolism*; D013464:Sulfuric Acids / Q000378:metabolism; D013737:Testis / Q000378:metabolism*
D000728:Androgens; D000970:Antineoplastic Agents; D045166:Estradiol Congeners; D009943:Organophosphorus Compounds; D013256:Steroids; D013464:Sulfuric Acids; C018370:pregnenolone sulfate; D011374:Progesterone; D004958:Estradiol; D004054:Diethylstilbestrol; D011284:Pregnenolone; C004955:fosfestrol; C008958:polyestradiol phosphate